Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cencora (COR) Asset Writedowns and Impairment (2016 - 2025)

Cencora (COR) has disclosed Asset Writedowns and Impairment for 17 consecutive years, with $249.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Writedowns and Impairment rose 6345.31% year-over-year to $249.5 million, compared with a TTM value of $1.1 billion through Dec 2025, up 3646.51%, and an annual FY2025 reading of $837.4 million, up 1950.69% over the prior year.
  • Asset Writedowns and Impairment was $249.5 million for Q4 2025 at Cencora, down from $791.9 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $791.9 million in Q3 2025 and bottomed at -$1.5 million in Q4 2022.
  • Average Asset Writedowns and Impairment over 5 years is $75.0 million, with a median of $11.8 million recorded in 2024.
  • The sharpest move saw Asset Writedowns and Impairment plummeted 130.04% in 2022, then soared 7357.75% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at $4.9 million in 2021, then tumbled by 130.04% to -$1.5 million in 2022, then surged by 1163.12% to $15.8 million in 2023, then crashed by 75.5% to $3.9 million in 2024, then surged by 6345.31% to $249.5 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for COR at $249.5 million in Q4 2025, $791.9 million in Q3 2025, and $33.2 million in Q2 2025.